Cellebrite is recognized for cutting-edge solutions paired with end-to-end investigative workflow innovation
PETAH TIKVA, Israel and TYSONS CORNER, Va., April 22, 2022 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced that it has been named a Leader in the inaugural IDC MarketScape: Worldwide Digital Forensics in Public Safety 2022 Vendor Assessment (doc #US48999722) April 2022.
This IDC MarketScape assessed six vendors across 11 core capabilities, including customer satisfaction, data discovery, data analysis, usability, reporting and pricing, and 9 different strategic areas such as growth, innovation, sales, distribution, and deployment. It is the first time this growing market has been analyzed as an IDC MarketScape and the report offers unrivalled insight into the current vendor landscape.
According to the report, “Cellebrite’s investment in R&D is a sizeable component of its total revenue; customer references confirmed the value that this brings to its product suite.” It also quotes a Cellebrite customer saying, “research and development keeps them at the forefront of technological development and therefore offers cutting edge solutions.”
The IDC MarketScape explains that “[Cellebrite’s] user interface feels like best-in-class, fresh, next-generation technology; it is intuitive and easy to use, yet also both thorough and speedy.” It also states that Cellebrite customers “noted that the scope of the devices supported is unmatched by its competitors.”
The report also acknowledges that “Cellebrite is focused on cloud delivery models to provide flexibility and agility in data processing and AI for workflow automation, specifically in image processing,” and that “Cellebrite has some considerable IP in visual analytics.”
Yossi Carmil, CEO of Cellebrite, comments: “Law enforcement agencies across the globe are relying heavily on vendors in this space to collect, manage, and analyze the growing volume of digital evidence that is essential to running more effective and efficient investigations to keep the public safe. We are proud that IDC MarketScape has named Cellebrite a Leader in digital forensics in public safety, which is a key part of our overall end-to-end digital intelligence offering.”
Dr Alison Brooks, Research Vice President for IDC’s Worldwide and US Public Safety practice, comments: “In recent years, the digital forensics market has grown significantly, and the landscape of vendors has become more complex. Cellebrite understands the nuanced ways criminal activity has evolved with more stealth and encrypted platforms. Its position in the Leaders Category reflects its cutting-edge R&D and end-to-end investigative workflow innovation, as it seeks to enable its customers with solutions to address the challenges and rising complexity of digital investigations.”
To learn more about Cellebrite, its capabilities and position as a Leader in the IDC MarketScape Assessment visit: https://cellebrite.com/en/idc-marketscape-names-cellebrite-a-leader/
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
About Cellebrite
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on Twitter at @Cellebrite.
Caution Regarding Forward Looking Statements
This document includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward looking statements include estimated financial information. Such forward looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of Cellebrite’s business are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the acceptance of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; uncertainties regarding the impact of macroeconomic and/or global conditions, including COVID-19 and military actions involving Russia and Ukraine; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; political and reputational factors related to Cellebrite’s business or operations; risks relating to estimates of market opportunity and forecasts of market growth; Cellebrite’s ability to properly manage its growth; risks associated with Cellebrite’s credit facilities and liquidity; Cellebrite’s reliance on third-party suppliers for certain components, products, or services; challenges associated with large transactions and long sales cycle; risks that Cellebrite’s customers may fail to honor contractual or payment obligations; risks associated with a significant amount of Cellebrite’s business coming from government customers around the world; risks related to Cellebrite’s intellectual property; security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions; the mishandling or perceived mishandling of sensitive or confidential information; the complex and changing regulatory environments relating to Cellebrite’s operations and solutions; the regulatory constraints to which we are subject; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on form 20-F filed with the SEC on March 29, 2022 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Contacts
Media
Adam Jaffe
VP of Global Communications
+1 973 206 7643
adam.jaffe@cellebrite.com
– or –
RapidResponse@cellebrite.com
Investors
Anat Earon-Heilborn
VP Investor Relations
+972 73 394 8440
investors@cellebrite.com
![[Figure 1] Seegene unveils world's first commercialized '3 Ct' PCR assay](https://ci5.googleusercontent.com/proxy/dmzdi_75eUGgvErhMGK7OBswaoGD_PCPzTNbV8snCgWP-6SSLPdJVl1zP_7FvpzLhrbiM0FcoyBxdKzASlr2TDQYTX8GTJM=s0-d-e1-ft#https://mma.prnewswire.com/media/1804637/image_1.jpg "[Figure 1] Seegene unveils world's first commercialized '3 Ct' PCR assay")
